RO5285119 + fluoxetine

RO5285119 + fluoxetine is a **combination of two pharmaceuticals:** RO5285119 (also known as balovaptan), a small molecule vasopressin V1a receptor antagonist developed primarily for autism spectrum disorder, and fluoxetine, a selective serotonin reuptake inhibitor (SSRI) widely used for depression, anxiety disorders, and other psychiatric conditions. RO5285119 (balovaptan) acts as a vasopressin V1a receptor antagonist and modulates social behavior pathways in the brain, while fluoxetine increases serotonergic neurotransmission by inhibiting serotonin reuptake. There is no evidence of a marketed fixed-dose or co-packaged product containing this exact combination, nor specific clinical development for the combination beyond their individual uses.

Other names

balovaptan + fluoxetine